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ABSTRACT 
The Effect of Radiation, Diet, and Microgravity on Colonocyte Gene Expression 
 
Ryan J. Bindel 
Department of Veterinary and Biomedical Science  
Texas A&M University 
 
Research Advisor: Dr. Nancy Turner 
Department of Nutrition and Food Science 
Texas A&M University 
 
 
Recent progress has been made in understanding the physiological responses to 
conditions prevalent in the space flight environment, including radiation source, duration of 
radiation exposure, weightlessness, and diet. The aim of this project was to use an experimental 
model simulating the space environment to investigate the immune response with exposure to 
oxidative stress, weightlessness, and continuous low dose ionizing radiation. Mice were 
randomly assigned to groups according to a 2 x 2 x 2 factorial design of continuous cobalt (60Co) 
radiation (C-RAD) or no radiation (SHAM), weight bearing or hind limb unloaded, and a diet 
with high or normal iron levels. The mice (n=50) were given a 45 or 650 mg iron/kg diet, and 
maintained in a full body head down tilt for 42 days during the radiation treatment phase. 
Continuous radiation (C-RAD) mice were exposed to a whole-body dose of 60Co gamma (γ) 
radiation on a continuous basis (0.5 mGy/hour) over the 6-week HU period, resulting in a total 
dose of 0.5 Gy. A malfunction in the RT-PCR machine during our first set of analyses resulted in 
no data being acquired. Unfortunately, this caused a decrease in the number of samples available 
for subsequent analysis. The decrease in available samples resulted in it only being feasible to 
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make comparisons using a 2 x 2 factorial design of dietary iron level and hind limb unloaded 
state. The remaining treatment groups received the normal dietary iron and were cage controls 
(CC, n=3), or hind limb unloaded (HU, n=4), or they received the high iron diet (CC + Fe, n=4; 
HU + Fe, n=4). Gene targets of interest (TNF-, and Slc5a8) were analyzed and the data 
normalized using 18S RNA. There were no significant changes in expression of TNF- and 
Slc5a8 caused by the elevated iron diet or hind limb unloading or their interaction. Even though 
there were no significant differences, there is a demonstrated tendency for increased expression 
of TNF- and Slc5a8 in all treatment groups, relative to the cage controls receiving the normal 
iron diet. These observations suggest the potential for these variables to have an impact on 
intestinal and systemic health of astronauts. More experiments with greater numbers of 
observations are necessary to explore the effects of radiation, diet, and weightlessness. 
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CHAPTER I 
INTRODUCTION 
 
Radiation Insult 
The inflammatory response and oxidative damage caused by ionizing radiation in space 
presents major concerns for the health of astronauts. Astronauts are exposed to high energy 
protons and ions (HZE), and low linear energy transfer rays (LET) from galactic cosmic rays 
while travelling in space. The difference between the types of radiation sources involves the 
amount of energy imparted from the radiation to the medium of passage per unit length (21). 
 
Figure 1. An overview of radiation damage effects observed leading to human cancer (6).  
It has been shown that high-LET 56Fe radiation produces more incidents of intestinal 
tumorigenesis of epithelial cells relative to low LET radiation (18). Despite this, we know that 
ionizing radiation on earth does promote carcinogenesis (29). Low LET radiation is known to alter 
the cell cycle, induce tumorigenesis by genomic instability and genetic mutations (5). In addition, 
oxidative stress is elicited and found to have elevated reactive oxygen and nitrogen species, ROS 
and RNS respectively (30).  
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Microgravity  
The experimental design allowed insight into the intestinal perturbation caused by 
microgravity (24). Though not well studied in the colon, microgravity is known to alter fluid 
circulation, muscle atrophy, bone mineralization, and immune dysregulation (14, 22, 25). It has been 
shown that mucosal cytokine levels in hind limb unloaded mice are altered by elevated IL-6 and 
suppressed IL-10 (24). This altered homeostasis between pro- and anti- inflammatory cytokines, 
respectively, contribute to an overall pro-inflammatory state in the intestine.  
Elevated Iron 
High iron stores induced by increased dietary iron levels may stimulate reactive oxygen 
species (ROS) generation, which would contribute to oxidative stress (1). Excessive ROS is 
known to increase cells sensitivity to radiation (2), and exposure to ionizing radiation also 
contributes to systemic oxidative stress (3).  Enhanced oxidative damage can result from the 
Fenton reaction, a reaction promoted by free iron ions, in which superoxide anions are converted 
to form highly reactive hydroxyl radicals. During the initial weeks of spaceflight, red blood cell 
numbers are decreased due to lysis, which also contributes to increased body iron stores (12). Free 
radicals can also affect many metabolic processes, including those that regulate DNA, RNA, 
proteins, and lipids (15). ROS produced from these processes and as a result of chronic 
inflammation can cause DNA damage, promote carcinogenesis, and long term immune system 
alteration (3).  
Human- Microbe Symbiosis 
 The gastrointestinal tract hosts on the order of 1014 microorganisms that play a role in 
contributing or detracting from the overall health of the human host. The disruption of the 
human-microbe symbiotic relationship can eventually result in the risk of developing 
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Inflammatory Bowel Disease, Irritable Bowel Syndrome, diabetes, asthma, and cancer (20, 33). The 
profile of an individual’s microbial population is known to change over time according to 
alterations in diet, antibiotic intake, or injury such as radiation. Identification of the changes in 
bacterial population can be studied by the molecules produced by bacterial metabolism in the 
intestine.  
As it relates to the colon, microbiota can use dietary fiber and starch polysaccharides as a 
source of energy and nutrient source for bacteria growth. Short Chain Fatty Acids (SCFAs), such 
as acetate, propionate, and butyrate, are produced by the fermentation of dietary fiber. Of the 
three, butyrate holds the most preventive potential in cancer by promoting cell cycle arrest, 
apoptosis, cell differentiation and suppressing colonic inflammation (32). The link between health 
benefits and intake of dietary fiber by butyrate help to show the importance of this mechanism in 
colonic health. 
It has been shown that butyrate is transported by a plasma membrane protein expressed 
by the gene Slc5a8 (34). The protein transports butyrate into the cell where it acts to inhibit 
histone deacetylases (HDACs). HDACs serve to regulate the expression of proteins that regulate 
the cell cycle and progression of cancer (35, 36). The lack of inhibition by butyrate explains recent 
findings that there is an inverse relationship between cancer incidence and levels of butyrate in 
the colon (37). For these reasons, the Slc5a8 gene is defined as a tumor suppressor gene, usually 
silenced in colon cancer to evade apoptosis, or natural cell regulated death. 
Inflammation in the Colon 
Toll Like Receptors (TLRs) found in the epithelial tissues of the gastrointestinal tract 
function to recognize microbial pathogens and initiate an appropriate immune response. TLRs 
have been found to play a role in chronic inflammation by creating inflammatory mediators such 
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as TNF-, IL-6, IL-10 (31). Changes in cytokine levels is consistent with Irritable Bowel Diseases 
such as Crohn’s disease or ulcerative colitis, often a precursor for intestinal cancer (27, 28). 
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CHAPTER II 
METHODS 
 
Diet 
The AIN 93G diet was used for the duration of the study. The iron level in the control 
diets was provided by ferric citrate (45 mg iron/kg), which provided a level that satisfies mouse 
iron requirements. The high Fe diet included 650 mg iron/kg, which has been used by others to 
model a moderately high iron diet that results in increased oxidative damage (15). The diet was 
introduced 4 weeks prior to starting the HU or C-RAD treatment.  
Hind Limb Unloading 
Mice were suspended using the tail ring method of Ferreira et al. (16). The hind limb 
unloading model simulates weightlessness by maintaining a full body head down tilt. The mice 
underwent hind limb unloading for the 42 days, during which the same radiation treatment 
occurred.  
Radiation Exposure 
Continuous radiation (C-RAD) mice were exposed to a whole-body dose of 60Cobalt 
gamma (γ) radiation on a continuous basis (0.5 mGy/hour) over the 6-week HU period, resulting 
in a total dose of 0.5 Gy. Activated cobalt wires were placed around a standard animal housing 
cage rack to provide continuous low level exposure. 
Sample Collection 
Procedures used for collection and analysis of scraped colon mucosa followed the 
procedures previously published by our lab (19,20). Mice were euthanized by CO2 asphyxiation 
followed by cervical dislocation. The colon was removed and luminal contents placed into a 
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cryotube and frozen in liquid nitrogen. The colon was flushed with RNase free PBS and cut in 
half longitudinally. One half was scraped to collect the mucosa that was used for gene expression 
analysis, and the other half processed for histological analysis. Mucosa was scraped from the 
colon on an RNase free surface (glass on ice) and transferred to an RNase free homogenization 
tube along with 250 μl of Denaturation solution (Ambion). Scraped mucosa was homogenized 
for at least six strokes and then transferred to a 2 mL eppitube for storage at -80°C. 
Gene Expression 
RNA from the colonic mucosal scraping was isolated using a ToTALLY RNA kit 
(Ambion, Austin, TX) followed by DNase treatment (DNA-free Kit, Ambion, Austin, TX). The 
concentrations of mRNA were collected using spectrophotometry nanodrop. RNA quality was 
checked using an Agilent 2100 Bioanalyzer with nanochips or picochips depending on the 
concentration of RNA (RNA 6000 Nano LabChip). Expression of TNF-, IL-6, IL-10, and 
Slc5a8 were analyzed via real time PCR using TaqMan Array plates and a ABI7900 HT real-
time thermocycler. Control genes of 18S and GAPDH were used to normalize results. PCR 
conditions were as follows: 
 UDG Incubation    2 min   50 C 
 AmpliTaq, Gold, UP Activation  10 min   95 C 
 PCR  (40 Cycles) 
  Denature    15 sec   95 C 
  Anneal/Extend   1 min   60 C 
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Table 1. Target and control gene assay information 
Gene Symbol Catalog Number TaqMan Assay ID  
TNF- 4331182 Mm00443258_m1 
IL-6 4331182 Mm00446190_m1 
IL-10 4331182 Mm01288386_m1 
Slc5a8 4331182 Mm00520629_m1 
GAPDH 4331182 Mm99999915_m1 
18S 4331182 Mm03928990_m1 
 
Preliminary Experiment  
The amount of input cDNA (100 ng, 10 ng, 1 ng, 0.1 ng) was tested in a preliminary RT-
PCR reaction to identify the most appropriate amount of cDNA for each gene target. Based on 
cycle threshold values for all tested genes above, only TNF- and Slc5a8 produced sufficiently 
repeatable results. IL-6 and IL-10 were not used as a gene of interest in further expression 
analysis.  
Statistical Methods 
Results from the RT- PCR analyses were derived using the comparative Ct method for 
relative quantifications (38). The data were analyzed using the General Linear Model (GLM) with 
the SAS (version 9.4) program. The samples were tested for differences in main effects and 
interaction effects due to diet, hind limb unloading, and radiation. 
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CHAPTER III 
RESULTS AND CONCLUSION 
 
Results 
The amount of mRNA isolated from the colon scraped mucosa samples was determined 
to calculate the amount of starting material to reverse transcribe in to cDNA in later steps. Table 
1 in Appendix A holds the spectrophotometry and RNA quality data for all samples. Nucleic acid 
absorbance maximums are at 260nm and 280nm, and phenol or protein contamination produce a 
signal at 230nm. The 260/280 absorbance ratio is used to determine the purity of the nucleic 
acids present, where acceptable ratios are between 1.8 and 2.0. The 260/230 ratio is an 
assessment used to determine phenol contamination, with acceptable ratios commonly being 
between 2.0 and 2.2. The observed 260/280 mean was 1.945  0.155 and the 260/230 ratio mean 
was 0.640  0.437. 
The Agilent Bioanalyzer produced the RNA Integrity Number (RIN) which demonstrated 
a secondary sense of quality of RNA in addition to spectrophotometry. A RIN is generated by 
the detected 18s and 28s RNA peaks, and is a quantifiable measure of the degradation caused by 
RNase enzymes. Shorter fragments of degraded RNA can compromise gene expression analysis. 
Acceptable sample RIN result is between 8 and 10, therefore any sample with a RIN value below 
8.0 was not used in later steps of analysis. The Agilent RNA 6000 Nano Kit Guide pictures the 
peaks expressed by the reaction below (Figure 2). 
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Figure 2. Factors in analysis of RNA quality 
Gene Expression by RT-PCR 
The RT-PCR runs were not usable because of a malfunction in the ABI7900 HT real-time 
thermocycler. A follow up experiment was conducted using a Roche 480 machine to obtain 
results. Not all samples could be used in the follow up experiment due to a limited amount of 
initial RNA available. All cycle threshold data can be found in Table 2 in Appendix A. The 
decrease in available samples for data analysis meant we were only able to compare results from 
a 2 x 2 factorial design of altered diet and hind limb unloaded state with CC (n=3), HU (n=4), 
CC + Fe (n=4), and HU + Fe (n=4).   
The mean expression of TNF- in the scraped colon mucosa from the cage control mice 
was 1.920 .881 (Table 2, Figure 3). The expression of TNF- in all other treatment groups 
tended to be higher (HU is a 203%, CC + Fe is a 185%, and HU + Fe is a 207% increase). The 
expression of Slc5a8 in the scraped colon mucosa was also lower in the cage control mice 
(Figure 4). Increasing dietary iron or incorporating hind limb unloading also tended to increase 
expression of Slc5a8 (HU is a 789%, CC + Fe is a 1184%, HU + Fe is a 846% increase). 
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Table 2. Changes in gene expression in the colon relative to 18S 
 High Fe Normal Fe Main Effect  
P values 
Interaction 
effects  
P values  
Gene CC HU CC HU Diet HU Diet + HU 
TNF- 3.550  
1.330 
3.975  
1.330 
1.920 
.881 
3.888  
1.330 
0.224 0.226 0.224 
Slc5a8 1.504  
0.612 
1.074  
0.612 
0.127  
0.865 
1.002  
0.612 
0.491 0.319 0.463 
Values are least squares means with standard error of the mean for each gene. Data are presented 
relative to the expression of reference gene (18S). P values are included for main effects and 
interaction effects. 
 
Figure 3. Gene expression for TNF- normalized to 18S 
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Figure 4. Gene expression for Slc5a8 normalized to 18S 
Discussion 
A previous study using rats demonstrated that as the levels of oxidative stress and 
inflammatory tone in the colon increased in response to elevated dietary iron and low LET 
radiation, the expression of several genes involved in inflammation and SCFA transport also 
changed (19). That research suggests the expression of Slc5a8 should be lower and that of TNF- 
should be higher relative to a weight bearing and normal iron diet control in this experiment (19). 
Figure 3 and 4 document an overall tendency for an increase expression of TNF- and Slc5a8 of 
mice given either elevated iron diets or are hind limb unloaded, relative to the low dietary iron 
cage control mice. This tendency is reflective of alterations in gene expression reported to occur 
in response to diet and microgravity experienced by astronauts in space (14).  The small sample 
numbers available for this work prohibited our ability to detect treatment differences.  However, 
the pattern of responses observed suggests that these treatments may induce meaningful changes 
in the intestine. 
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In colorectal cancer, Slc5a8 is known to be a tumor suppressor gene and is usually down 
regulated in colon cancer, whereas TNF- upregulation in colon mucosa is associated with 
increased CRC incidence (37, 39). Recent research has explored potential drug therapies for 
inhibition of TNF- to prevent the growth of tumors in CRC (40). The effect of these two 
variables on the expression of these genes may be contributing to the incidence of CRC in 
astronauts.  The Longitudinal Study of Astronaut Health has determined that a diagnosis of 
benign or malignant neoplasm incidence is occurring at a higher rate compared to a group of 
comparison participants (41).  
Conclusion 
Using a high iron diet or hind limb unloading to model the spaceflight environment did 
not produce statistically significant changes of colonic gene expression of TNF- and Slc5a8 in 
this experiment.  Variability in the animal responses in combination with low sample numbers 
precludes our ability to detect significant differences.  However, there is a demonstrated 
tendency for increased expression of TNF- and Slc5a8 with either an increase in dietary iron or 
with hind limb unloading.  These preliminary observations suggest these space-relevant variables 
may contribute to immunological perturbations of the intestine mucosa and the altered 
relationship between gut microbiota and the human host. These changes may impact colon and 
overall health of the astronauts during spaceflight.  
 The results would be improved in future experiments with larger sample numbers. More 
experiments will be necessary to explore the effects of radiation, diet, and weightlessness to 
model the astronaut environment. Future research can expand the scope of genes of interest to 
other inflammatory pathways that are involved in colon health. 
  
16 
REFERENCES 
 
1. Li M, Gonon G, Buonanno M, Autsavapromporn N, de Toledo SM, Pain D, Azzam EI. 
Health risks of space exploration: targeted and nontargeted oxidative injury by high-
charge and high-energy particles. Antioxid Redox Sign. 2014;20:1501-1523. 
 
2. Dayal R, Singh A, Pandey A, Mishra KP. Reactive oxygen species as mediator of tumor 
radiosensitivity. J Canc Res Ther. 2014;10:811-818. 
 
3. Kennedy AR, Guan J, Ware JH. Countermeasures against space radiation induced 
oxidative stress in mice. Radiat Environ Biophys. 2007;46:201-203. 
 
4.  Chang ML, Hou JK. Cancer risk related to gastrointestinal diagnostic radiation exposure. 
Curr Gastroenterol Rep. 2011;13:449–57. 
 
5.    BEIR. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing   
Radiation. National Research Council of the National Academies: Health risks from 
exposure to low levels of ionizing radiation. BEIR VII – Phase 2. The National 
Academies Press, Washington, D.C. 2006.  
 
6.    Hanahan D, Weinberg RA. The hallmarks of cancer. Oxford Textbook of Oncology. 
2016;3–10.  
 
7. Li H, Myeroff L, Smiraglia D, Romero MF, Pretlow TP, Kasturi L, et al. SLC5A8, a 
sodium transporter, is a tumor suppressor gene silenced by methylation in human colon 
aberrant crypt foci and cancers. Proc Natl Acad Sci USA. 2003;100:8412–8417. 
 
8.  Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011; 
140:1807-1816. 
 
9. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal 
microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 
2013;368:1575-1584. 
17 
10.  Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, et al. Ulcerative 
colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. 
BMC Gastroenterol. 2010;10:134 
 
11. Sepehri S, Kotlowski R, Bernstein CN, Krause DO. Microbial diversity of inflamed and 
noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 
2007;13:675-683. 
 
12.  Alfrey CP, Udden MM, Leach-Huntoon C, Driscoll T, Pickett MH. Control of red 
blood cell mass in spaceflight. J Appl Physiol. 1996;81:98-104. 
 
14.  Globus RK, Morey-Holton E. Hindlimb unloading: rodent analog for microgravity. J 
Appl Physiol. 2016;120:1196-1206.  
 
15.  Fischer JG, Glauert HP, Yin T, Sweeney-Reeves ML, Larmonier N, Black MC.  
Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect 
NF-kappaB activation induced by the peroxisome proliferator. J Nutr. 2002;132:2525-31. 
 
16. Ferreira JA, Crissey JM, Brown M. An alternant method to the traditional NASA 
hindlimb unloading model in mice. J Vis Exp. 2011l;49. 
 
17. Datta K, Suman S, Kallakury BV, Fornace AJ, Jr. Exposure to heavy ion radiation 
induces persistent oxidative stress in mouse intestine. PLoS One. 2012; 
10.1371/journal.pone.0042224. 
 
18. Trani D, Datta K, Doiron K, Kallakury B, Fornace AJ, Jr. Enhanced intestinal tumor 
multiplicity and grade in vivo after HZE exposure: mouse models for space radiation risk 
estimates. Radiat Environ Biophys. 2010;49:389-396. 
 
19.  Morgan JL, Ritchie LE, Crucian BE, Theriot C, Wu H, Sams C, Smith SM, Turner ND, 
Zwart SR. Increased dietary iron and radiation in rats promote oxidative stress, induce 
localized and systemic immune system responses, and alter colon mucosal environment. 
FASEB J. 2014;28:1486-1498. 
 
18 
20. Ritchie LE, Taddeo SS, Weeks BR, Lima F, Bloomfield SA, Azcarate-Peril MA, Zwart 
SR, Smith SM, Turner ND. Space Environmental Factor Impacts upon Murine Colon 
Microbiota and Mucosal Homeostasis. PLoS One. 2015; 10.1371/journal.pone.0125792. 
 
21. Friedberg W, Copeland K. Ionizing Radiation in Earth’s Atmosphere and in Space Near 
Earth. 2011. 
 
22. Morey-Holton ER, Globus RK. Hindlimb unloading rodent model: technical aspects. 
Journal of Applied Physiology. 2002;92:1367-1377  
 
23. Zheng, et al. Gene expression profiling in non-human primate jejunum, ileum and colon 
after total-body irradiation: a comparative study of segment-specific molecular and 
cellular responses. BMC Genomics. 2015;16:984. 
 
24.  Li P, Shi J, Zhang P, Wang K, Li J, Liu H, Zhou Y, Xu X, Hao J, Sun X et al. Simulated 
microgravity disrupts intestinal homeostasis and increases colitis susceptibility. FASEB 
J. 2015;29:3263-3273. 
 
25. Williams D, Kuipers A, Mukai C, Thirsk R. Acclimation during space flight: effects on 
human physiology. CMAJ. 2009;180:1317-1323. 
 
26. Smith SM, Zwart SR. Nutritional Biochemistry of Spaceflight: Advances in Clinical 
Chemistry. 2008;87–130. 
 
27.  Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–
342. 
 
28. Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. Mucosal cytokine 
network in inflammatory bowel disease. World J of Gastroenterolo. 2008;14:5154-5161. 
 
29. Brenner DJ, Hricak H. Radiation exposure from medical imaging: time to regulate? 
JAMA. 2010;304:208–209. 
 
19 
30.  Baulch JE, Craver BM, Tran KK, Yu L, Chmielewski N, Allen BD, Limoli CL. 
Persistent oxidative stress in human neural stem cells exposed to low fluences of charged 
particles. Redox Biol. 2015;24–32. 
 
31. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J 
Biochem Cell Biol. 2010;42:506-18. 
 
32. Ganapathy V, Thangaraju M, Prasad PD, Martin PM, Singh N. Transporters and
 receptors for short-chain fatty acids as the molecular link between colonic bacteria
 and the host. Curr Opin Pharmacol. 2013;13:869-874. 
 
33. Derrien M, Veiga P. Rethinking Diet to Aid Human-Microbe Symbiosis. Trends 
Microbiol. 2017;25:100-112. 
 
34.  Thangaraju M, Cresci G, Itagaki S, Mellinger J, Browning DD, Berger FG, Prasad PD, 
Ganapathy V. Sodium-coupled transport of the short chain fatty acid butyrate by 
SLC5A8 and its relevance to colon cancer. J Gastrointest Surg. 2008;12:1773-1781; 
discussion 1781-1772. 
 
35. Chen JS, Faller DV, Spanjaard RA. Short-chain fatty acid inhibitors of histone 
deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets. 2003;3:219-
236.  
 
36.  Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene. 2007;26:5420-5432. 
 
37. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, 
Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC. 
AICR. 2007. 
 
38.  Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT 
method. Nature Protocols. 2008; 1101-1108. 
 
39.  Al Obeed OA, Alkhayal KA, Al Sheikh A, et al. Increased expression of tumor necrosis 
factor-α is associated with advanced colorectal cancer stages. WJG. 2014;20:18390-
18396. 
 
20 
40.  Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-alpha and its inhibitors in cancer. Med 
Oncol. 2010;27:185–198.   
 
41.  National Aeronautics and Space Administration. Colorectal Cancer Incidence of LSAH 
Participants. In: Longitudinal Study of Astronaut Health Newsletter. December 1999;8:2. 
 
  
21 
APPENDICES 
 
Appendix A -Experiment Data  
 
Table 1. Spectrophotometry and RNA quality data for all experimental mice 
Animal ID Design Concentration 
(ng/ul) 
260/280 
ratio 
260/230 
ratio 
RNA Integrity 
Number (RIN) 
1102 CC 70.12 2.06 0.26 10 
1106 CC 134.29 2.03 1.68 10 
1206 CC 12.27 1.72 0.24 9.6 
1208 CC 35.16 1.87 0.51 2.4 
1211 CC 3.74 1.61 0.06 7.9 
1218 CC 24.02 1.77 0.24 10, 8 
1219 CC 56.36 1.74 0.75 9.8 
1222 CC 27.6 1.87 0.36 8.6 
1223 CC 36.11 1.86 1.07 2.4 
1230 CC 75.65 1.95 0.45 10 
1233 CC 45.93 1.92 0.39 9.8 
1234 CC 43.42 1.96 0.71 9.8 
1235 CC 10.11 1.94 0.26 5.5 
1107 CC+Fe 96.77 1.97 1.02 9.8 
1108 CC+Fe 81.91 1.98 1 9.8 
1109 CC+Fe 167.86 2.01 1.53 10 
1110 CC+Fe 107.75 2.05 1.82 9.9 
1111 CC+Fe 143.32 2.03 0.46 9.9 
1112 CC+Fe 162.67 2.03 1.81 9.9 
1114 CC+Fe 82.49 2 0.72 10 
1214 CC+Fe 34.37 1.96 0.39 6.4 
1216 CC+Fe 37.16 1.9 0.65 - 
22 
1225 CC+Fe 32.06 2.01 0.37 9.1 
1228 CC+Fe 24.46 1.92 0.34 9.2 
1229 CC+Fe 43.25 1.97 0.36 5.1 
1101 HU 149.97 2.03 1.7 10 
1104 HU 132.22 2.01 0.94 10 
1105 HU 131.78 2.02 1.08 10 
1207 HU 40.02 1.88 0.61 8.4 
1209 HU 62.94 1.98 0.41 9.7 
1210 HU 28.13 2.08 0.22 8.9 
1220 HU 17.99 1.86 0.13 9.5 
1221 HU 86.26 2.01 0.69 9.9 
1231 HU 52.3 1.9 0.56 10 
1232 HU 34.27 1.98 0.39 9.5 
1103 HU  106.19 2.03 1.28 8.7 
1113 HU+Fe 117.03 2.01 1.24 9.9 
1115 HU+Fe 3.46 1.72 0.06 1.1 
1201 HU+Fe 42.52 1.97 0.7 10 
1203 HU+Fe 40.45 1.91 0.58  
1204 HU+Fe 51.95 2.02 0.2 10 
1205 HU+Fe 44.64 2.04 0.94 9.3 
1212 HU+Fe 71.75 1.63 0.43 9.8 
1213 HU+Fe 57.96 1.95 0.68 9.9 
1224 HU+Fe 41.29 1.87 0.61 2.4, 5.8 
1227 HU+Fe 70.84 1.76 0.52 10 
1800 Rad 165.55 1.55 0.6 5.2 
1801 Rad 24.66 1.65 0.25 4.3 
1808 RadFe 49.92 2.05 0.93 6.9 
1809 RadFe 9.22 2.06 0.13 8.1 
1810 RadFe 56.82 1.64 0.58 9.2 
1811 RadFe 23.65 2.11 0.15 9.1, 5.3 
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1812 RadFeHU 27.3 2.03 0.45 8 
1813 RadFeHU 37.89 2 0.78 2.4 
1814 RadFeHU 45.87 1.98 0.36 5.6 
1815 RadFeHU 15.63 2.15 0.52 2.7, 5.7 
1816 RadFeHU 53.52 1.68 0.53 1 
1817 RadFeHU 26.19 2.1 0.45 10 
1818 RadFeHU 40.41 2.01 1.1 7.6 
1819 RadFeHU 46.04 1.86 0.52 8.4 
1820 RadFeHU 37.75 2.05 0.66 5.5 
1821 RadFeHU 11.99 1.94 0.21 5.9 
1802 RadHU 17.42 2.07 0.69 4.6 
1803 RadHU 3.9 2.62 0.07 8.9 
1804 RadHU 25.21 1.96 0.89 7.8 
1805 RadHU 78.97 2.05 1.63 7.9 
1806 RadHU 26.8 1.89 0.42 9.7 
1807 RadHU 16.63 2.04 0.17 10, 2 
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Table 2. Cycle Threshold Data for all Experimental Samples 
Animal 
ID 
Design  Triplicate 
CT values 
Gene 
   TNF- Slc5a8 GAPDH 18S 
12191 CC      
  1 38.88 34.83 34.54 31.67 
  2 36.92 33.76 33.36 31.76 
  3 36.98 33.86 33.89 31.7 
12331 CC      
  1 41.53 40.65 37.89 36.33 
  2 40.83 39.83 38.29 36.16 
  3 42.4 39.16 37.19 35.65 
12341 CC      
  1 39.47 39.14 41.94 42.93 
  2 38.67 37.47 ----- 40.6 
  3 38.64 37.62 ----- 41.39 
11071 CC+Fe      
  1 34.85 28.96 30.02 31.04 
  2 35.57 29.7 30.07 30.97 
  3 34.94 29.71 30.67 31.17 
11101 CC+Fe      
  1 33.38 28.23 27.45 28.08 
  2 33.54 27.29 29.68 29.96 
  3 33.99 27.86 28.5 27.86 
11111 CC+Fe      
  1 33.38 28.87 ----- 27.71 
  2 33.33 28.71 28.74 28.33 
  3 33.3 28.85 29.88 27.54 
11121 CC+Fe      
  1 32.33 28.19 28.07 27.98 
  2 32.66 28.25 28.48 27.78 
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  3 34.27 29.12 27.83 28.07 
11011 HU      
  1 33.4 29.54 29.57 29.57 
  2 33.84 28.67 30.03 29.63 
  3 32.7 29.27 28.89 28.83 
11041 HU      
  1 34.71 28.6 30.01 29.73 
  2 34.86 29.38 29.39 29.93 
  3 35.11 29.26 30.94 30.87 
12091 HU      
  1 34.31 30.8 30.52 28.86 
  2 34.48 31.09 29.93 28.89 
  3 34.91 30.42 30.75 32.7 
12211 HU      
  1 39.89 35.85 34.97 31.88 
  2 38.55 35.85 34.8 32.51 
  3 39.87 35.9 34.9 32.39 
12312 HU      
  1 ----- ----- 41.93 37.01 
  2 ----- ----- 41.35 40.21 
  3 ----- ----- ----- 40.6 
11131 HU+Fe      
  1 33.85 28.42 29.1 29.45 
  2 34 28.71 28.85 30.98 
  3 33.35 28.26 29.08 30.49 
12051 HU+Fe      
  1 33.89 29.95 28.32 27.62 
  2 33.64 31.97 28.47 27.94 
  3 33.67  28.73 27.97 
12121 HU+Fe      
  1 39.72 36.29 35.64 31.92 
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  2 39.45 36.56 35.88 31.87 
  3 38.84 37.09 36.37 32.03 
12131 HU+Fe      
  1 32.52 29.08 30.18 27.92 
  2 32.9 28.48 30.2 28.32 
  3 32.85 29.67 30.36 28.43 
18081 RadFe      
  1 35.88 32 31.98 33.58 
  2 35.98 31.83 32.73 27.83 
  3 35.92 32.09 32.47 28.72 
18102 RadFe      
  1 ----- 42.74 35.04 36.86 
  2 ----- ----- 39.68 37.81 
  3 ----- ----- 35.53 37.24 
18182 RadFeHU      
  1 ----- ----- ----- 42.27 
  2 ----- ----- ----- 40.82 
  3 ----- ----- ----- ----- 
18192 RadFeHU      
  1 ----- ----- 40.54 41.64 
  2 ----- ----- 41.84 41.45 
  3 ----- ----- 41.93 42.71 
 
Table 2. Cycle Threshold Data for all Experimental Samples. 1Samples were included for 
statistical analysis. 2Samples were not included in statistical analysis due to absence of cycle 
threshold output generated during RT- PCR.  
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Appendix B -Experimental Protocols 
 
Mucosal mRNA Isolation 
 
RNAqueous Kit (Applied Biosystems #AM1912) 
 
Handle all samples in RNase free conditions, including sample tubes, gloves, equipment etc.  
 
Prior to starting, heat 50 ul (per sample) aliquot of Elution Solution at 75 C.  
 
Reduce the viscosity of the lysate if necessary, ensure tissue is well homogenized. Use 25 gauge 
syringe needle to break up lysate.  
 
1- Add equal volume of 64% ethanol to the lysate and mix gently 
2- Apply the mixture from previous step to a filter cartridge in a supplied collection tube  
 ( max volume that can be applied is 700 ul) 
3- Centrifuge at RCF 10,000-15,000 x g for 1 minute, or until lysate/ethanol has passed through  
 the filter 
4- Discard flow through and keep collection tube 
5- Repeat step 3 as necessary until all the sample has been drawn through the filter. Add up to 
 700 ul 64% ethanol as necessary.  
6- Apply 700 ul Wash Solution #1 to the filter cartridge 
7- Centrifuge at RCF 10,000-15,000 x g for 1 minute, or until lysate/ethanol has passed through  
 the filter. Discard flow through and keep collection tube 
8- Add 500 ul Wash Solution 2/3 
9- Centrifuge at RCF 10,000-15,000 x g for 1 minute, or until lysate/ethanol has passed through  
 the filter. Discard flow through and keep collection tube 
10- Repeat steps 8 and 9 
11- Put filter cartridge into a fresh Collection Tube 
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12- Pipet preheated Elution Solution to the center of the filter (40 ul) 
13- Recover by centrifugation for 30 seconds at same speed above 
14- Repeat step 12 with only 10 ul Elution Solution 
 
Store isolated RNA in -80 C freezer conditions 
 
Post Isolation DNase Treatment for RNA 
 
Catalog Number: AM1912 
 
1- Add 0.1 Volume (for 50 ul elution  5 ul) 10X DNase 1 Buffer and 1 ul rDNase 1 to the 
RNA, and mix gently 
2- Incubate at 37 C for 20-30 minutes.  
3- Add re suspended DNase Inactivation Reagent (typically 0.1 volume  5.5 ul) and mix well 
4- Incubate 2 min at room temperature, mixing occasionally  
5- Centrifuge at 10,000 x g for 1.5 min and transfer the RNA to a fresh RNAse free tube. 
6- Aliquot 4 ul into RNase free PCR tube for Nanodrop and Agilent QC.  
 
Tubes needed:  
Filter Cartridge x1 per sample 
Collection Tube x2 per sample 
.65 ml RNase free tube x1 per sample (for post DNAse treatment collection) 
RNase free PCR Tube x1 per sample (for ND and Agilent aliquot) 
 
Spectrophotometry via Nanodrop for RNA 
 
1- Clean the upper and lower optical surfaces of the microspectrophotometer. Pipet 1 to 2 ul of 
clean deionized water to clean the system 
2- Open the NanoDrop software and select the nucleic acids module 
3- Initialize the spectrophotometer by placing 1 ul of clean water onto the lower optical surface, 
lowering the arm and selecting “initialize” in the software.  
4- Clean surface by wiping with Kimwipe 
5- Measure the nucleic acid sample by loading 1 ul and select “measure.” 
6- Record the concentration of nucleic acid I ng/ul and the ratios at 260/230 and 260/280 
 
Measuring RNA Quality 
 
1. Put ~5 μL of each sample in a labeled eppitube and place on ice. 
3. Analyze samles on a NanoChip using and Agilent 2100 Bioanalyzer using 
complementary software. 
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a. Make sure Bioanalyzer is connected to computer and power source. 
b. Turn on Bioanalyzer, make sure indicator light is green. 
c. Start Agilent 2100 Bioanalyzer software. 
d. Select Assay>RNA>mRNA nano 
e. Prepare samples, buffer, and nano chip. (See RNA 6000 Nano LabChip kit) 
f. Place chip in Bioanalyzer and close lid. 
g. Click “Start” above the chip icon. 
h. Ensure that sample names are all entered in the “Sample Information” tab. 
i. Change File Prefix and click “Start.” 
j. When the run is finished, clean as indicated by the See RNA 6000 Nano LabChip 
kit. 
k. Print Data. 
 
NOTES: 
 
RNA Integrity Number (RIN) 
>9 is optimal 
>8 is acceptable, if no errors are seen on the curve 
 
• Prepare and run chips within 10 minutes. Longer chip preparation times may lead to 
evaporation of buffers and to bad chip performance. 
• Vortex chips for appropriate 1 minute (not required for protein chips). Improper 
vortexing can lead to poor results. 
• Do not force the chip into the receptacle of the Agilent 2100 Bioanalyzer. Proper 
placement of the chip should not require force. Improper placement of the chip could 
damage the electrode assembly when you close the lid. Check whether the chip selector 
is in the correct position. 
• Do not touch wells of the chip. The chip could become contaminated, leading to poor 
measurement results. 
• Do not leave any wells of the chip empty or the assay will not run properly. Add 1 μL 
of sample buffer to each unused sample well. 
 
(From Thesis by Leigh Ann Piefer and methods done previously in this lab) 
 
SuperScript III First Strand Synthesis System for RT-PCR 
 
Catalog Number: 18080051 
 
1- Mix and centrifuge samples before conducting assay 
2- Combine the following in a 0.5 ul collection tube 
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- Up to 5 ug total RNA 
- Primer 
o 50 uM oligo(dT)20         1 ul 
 
3- Incubate the tube at 65 C for 5 min, then place on ice for at least 1 min, 
4- Prepare the following cDNA synthesis mix 
 10X RT buffer  2 ul 
 25 mM MgCl2   4 ul 
 0.1 M DTT   2 ul 
 RNaseOUT   1 ul 
 Superscripts III RT  1 ul 
 
5- Add the 10 ul of synthesis mix to the RNA mix and collect by brief centrifugation. Incubate at 
50 C for 50 minutes. 
6- Terminate the reaction at 85 C for 5 minutes. Chill on ice. 
7- Add 1 ul RNase H and incubate the tubes at 37 C for 20 minutes 
 
Store in -20 freezer or for PCR immediately  
 
Serial Dilutions for Practice RT-PCR using practice mice  
 
100 ng cDNA:  
 In one tube add 1.06 x 8 (8.48) ul cDNA and 7.94 x 8 (63.52) ul H20 
10 ng cDNA: 
Add 1 x 8 (8) ul of the tube from above to 9 x 8 (72) ul of H20 
1 ng cDNA 
Add 1 x 8 (8) ul of the tube from above to 9 x 8 (72) ul of H20 
0.1 ng cDNA 
Add 1 x 8 (8) ul of the tube from above to 9 x 8 (72) ul of H20 
 
TaqMan Gene Expression Master Mix 
 
Catalog Number: 4369016 
 
1- Start SDS program and ABI 7900 HT, allow time to heat and initialize  
2- Pipet all components in the chart below into 96 well plate 
 
Component Volume (ul) 
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TaqMan Gene Expression Master Mix 10 
TaqMan Gene Expression Assay 1 
cDNA template +H20 9 
total 20  
 
3- Run the PCR Plate using the “standard” cycling conditions 
 UDG Incubation    2 min   50 C 
 AmpliTaq, Gold, UP Activation  10 min   95 C 
 PCR     (40 Cycles) 
  Denature    15 sec   95 C 
  Anneal/Extend   1 min   60 C 
 
 
